Literature DB >> 24022590

The parity-associated microenvironmental niche in the omental fat band is refractory to ovarian cancer metastasis.

Courtney A Cohen1, Amanda A Shea, C Lynn Heffron, Eva M Schmelz, Paul C Roberts.   

Abstract

Ovarian cancer is an insidious and aggressive disease of older women, typically undiscovered before peritoneal metastasis due to its asymptomatic nature and lack of early detection tools. Epidemiologic studies suggest that child-bearing (parity) is associated with decreased ovarian cancer risk, although the molecular mechanisms responsible for this phenomenon have not been delineated. Ovarian cancer preferentially metastasizes to the omental fat band (OFB), a secondary lymphoid organ that aids in filtration of the peritoneal serous fluid (PSF) and helps combat peritoneal infections. In the present study, we assessed how parity and age impact the immune compositional profile in the OFB of mice, both in the homeostatic state and as a consequence of peritoneal implantation of ovarian cancer. Using fluorescence-activated cell sorting analysis and quantitative real-time PCR, we found that parity was associated with a significant reduction in omental monocytic subsets and B1-B lymphocytes, correlating with reduced homeostatic expression levels of key chemoattractants and polarization factors (Ccl1, Ccl2, Arg1, and Cxcl13). Of note, parous animals exhibited significantly reduced tumor burden following intraperitoneal implantation compared with nulliparous animals. This was associated with a reduction in tumor-associated neutrophils and macrophages, as well as in the expression levels of their chemoattractants (Cxcl1 and Cxcl5) in the OFB and PSF. These findings define a preexisting "parity-associated microenvironmental niche" in the OFB that is refractory to metastatic tumor seeding and outgrowth. Future studies designed to manipulate this niche may provide a novel means to mitigate peritoneal dissemination of ovarian cancer. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24022590      PMCID: PMC3836366          DOI: 10.1158/1940-6207.CAPR-13-0227

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  49 in total

1.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 2.  Cytokine-producing B lymphocytes-key regulators of immunity.

Authors:  Frances E Lund
Journal:  Curr Opin Immunol       Date:  2008-04-15       Impact factor: 7.486

3.  Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

Authors:  Luigi Dolcetti; Elisa Peranzoni; Stefano Ugel; Ilaria Marigo; Audry Fernandez Gomez; Circe Mesa; Markus Geilich; Gregor Winkels; Elisabetta Traggiai; Anna Casati; Fabio Grassi; Vincenzo Bronte
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

4.  Two physically, functionally, and developmentally distinct peritoneal macrophage subsets.

Authors:  Eliver Eid Bou Ghosn; Alexandra A Cassado; Gregory R Govoni; Takeshi Fukuhara; Yang Yang; Denise M Monack; Karina R Bortoluci; Sandro R Almeida; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

5.  Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21.

Authors:  Magdalena Hagn; Elisabeth Schwesinger; Verena Ebel; Kai Sontheimer; Julia Maier; Thamara Beyer; Tatiana Syrovets; Yves Laumonnier; Dorit Fabricius; Thomas Simmet; Bernd Jahrsdörfer
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

Review 6.  Immune infiltration in human tumors: a prognostic factor that should not be ignored.

Authors:  F Pagès; J Galon; M-C Dieu-Nosjean; E Tartour; C Sautès-Fridman; W-H Fridman
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

Review 7.  Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.

Authors:  Hilary A Kenny; Songuel Dogan; Marion Zillhardt; Anirban K Mitra; S Diane Yamada; Thomas Krausz; Ernst Lengyel
Journal:  Cancer Treat Res       Date:  2009

8.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

Authors:  Zvi G Fridlender; Jing Sun; Samuel Kim; Veena Kapoor; Guanjun Cheng; Leona Ling; G Scott Worthen; Steven M Albelda
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

9.  Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma.

Authors:  Hanne Krogh Jensen; Frede Donskov; Niels Marcussen; Marianne Nordsmark; Finn Lundbeck; Hans von der Maase
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

10.  Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.

Authors:  Katy Milne; Martin Köbel; Steven E Kalloger; Rebecca O Barnes; Dongxia Gao; C Blake Gilks; Peter H Watson; Brad H Nelson
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more
  21 in total

1.  Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.

Authors:  Nonna V Kolomeyevskaya; J Brian Szender; Gary Zirpoli; Albina Minlikeeva; Grace Friel; Rikki A Cannioto; Rachel M Brightwell; Kassondra S Grzankowski; Kirsten B Moysich
Journal:  Int J Gynecol Cancer       Date:  2015-11       Impact factor: 3.437

2.  Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.

Authors:  Wei-wei Zhang; Ke-jun Liu; Guo-lin Hu; Wei-jiang Liang
Journal:  Tumour Biol       Date:  2015-06-11

3.  Ovarian tumor-initiating cells display a flexible metabolism.

Authors:  Angela S Anderson; Paul C Roberts; Madlyn I Frisard; Matthew W Hulver; Eva M Schmelz
Journal:  Exp Cell Res       Date:  2014-08-27       Impact factor: 3.905

4.  A feasibility study for enrichment of highly aggressive cancer subpopulations by their biophysical properties via dielectrophoresis enhanced with synergistic fluid flow.

Authors:  Temple Anne Douglas; Jaka Cemazar; Nikita Balani; Daniel C Sweeney; Eva M Schmelz; Rafael V Davalos
Journal:  Electrophoresis       Date:  2017-05-08       Impact factor: 3.535

5.  Interleukin-12 Immunomodulation Delays the Onset of Lethal Peritoneal Disease of Ovarian Cancer.

Authors:  Courtney A Cohen; Amanda A Shea; C Lynn Heffron; Eva M Schmelz; Paul C Roberts
Journal:  J Interferon Cytokine Res       Date:  2015-10-02       Impact factor: 2.607

6.  Enhanced contactless dielectrophoresis enrichment and isolation platform via cell-scale microstructures.

Authors:  Jaka Čemažar; Temple A Douglas; Eva M Schmelz; Rafael V Davalos
Journal:  Biomicrofluidics       Date:  2016-01-19       Impact factor: 2.800

7.  Another Wrinkle with Age: Aged Collagen and Intra-peritoneal Metastasis of Ovarian Cancer.

Authors:  Elizabeth I Harper; Tyvette S Hilliard; Emma F Sheedy; Preston Carey; Paul Wilkinson; Michael D Siroky; Jing Yang; Elizabeth Agadi; Annemarie K Leonard; Ethan Low; Yueying Liu; Arya Biragyn; Christina M Annunziata; M Sharon Stack
Journal:  Aging Cancer       Date:  2022-04-19

8.  Self-aligned microfluidic contactless dielectrophoresis device fabricated by single-layer imprinting on cyclic olefin copolymer.

Authors:  Armita Salahi; Walter B Varhue; Vahid Farmehini; Alexandra R Hyler; Eva M Schmelz; Rafael V Davalos; Nathan S Swami
Journal:  Anal Bioanal Chem       Date:  2020-05-05       Impact factor: 4.142

9.  Fluid shear stress impacts ovarian cancer cell viability, subcellular organization, and promotes genomic instability.

Authors:  Alexandra R Hyler; Nicolaas C Baudoin; Megan S Brown; Mark A Stremler; Daniela Cimini; Rafael V Davalos; Eva M Schmelz
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

10.  Aging Increases Susceptibility to Ovarian Cancer Metastasis in Murine Allograft Models and Alters Immune Composition of Peritoneal Adipose Tissue.

Authors:  Elizabeth A Loughran; Annemarie K Leonard; Tyvette S Hilliard; Ryan C Phan; Madeleine G Yemc; Elizabeth Harper; Emma Sheedy; Yuliya Klymenko; Marwa Asem; Yueying Liu; Jing Yang; Jeff Johnson; Laura Tarwater; Zonggao Shi; Matthew Leevy; Matthew J Ravosa; M Sharon Stack
Journal:  Neoplasia       Date:  2018-05-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.